JAMA Medical News cover image

Clinical Highlights From the American Diabetes Association’s Scientific Sessions

JAMA Medical News

NOTE

Continuous Glucose Monitoring for Diabetes Management

Continuous Glucose Monitoring (CGM) has emerged as a major game-changer in diabetes care, offering significant benefits for individuals with type 1 and type 2 diabetes who are on insulin therapy. CGM usage has shown improvements in A1C levels and reduced hypoglycemia incidents. The American Diabetes Association recommends CGM for anyone on insulin, across all age groups. The approval of CGM by Medicare and commercial payers highlights the growing recognition and acceptance of this technology in diabetes management.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner